← Open Payments lookup

ROBERT WOOTEN: Open Payments

NPI 1922066232 · PINE BLUFF, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,220 in 65 payments from 11 companies in 2025. Trend: 2023 $961 · 2024 $904 · 2025 $1,220

Food & beverage: $1,220
CompanyPaymentsAmount
ABBVIE INC.18$317
Neurocrine BioSciences, Inc.10$224
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$158
Otsuka America Pharmaceutical, Inc.8$156
Janssen Pharmaceuticals, Inc8$150
Teva Pharmaceuticals USA, Inc.4$59
Alkermes, Inc.3$58
Lundbeck LLC2$33
Axsome Therapeutics, Inc.2$31
Vanda Pharmaceuticals Inc.1$22

Products named: VRAYLAR, INGREZZA, CAPLYTA, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII, UZEDY, VIVITROL.

Industry payments across AR — which companies pay providers there.